Ticker,Title,Link
IMUX,EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September,8/28/2024 12:30:04 PM
IMUX,Buy Rating Affirmed for Immunic’s MS Treatment Vido with Unique Dual Mechanism and Promising Clinical Data,8/27/2024 12:15:37 AM
IMUX,"Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)",8/13/2024 2:40:46 PM
IMUX,"EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results  and Provides Corporate Update",8/8/2024 12:30:03 PM
IMUX,Immunic Q2 2024 Earnings Preview,8/7/2024 3:07:59 PM
IMUX,"EQS-News: Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update",8/1/2024 12:30:05 PM
IMUX,"EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec",7/24/2024 12:30:05 PM
IMUX,Immunic Stock (IMUX): Striving to Develop Innovative Therapies,6/10/2024 7:33:40 AM
IMUX,Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying,5/23/2024 10:00:00 AM
IMUX,Hold Rating on Immunic Amidst Ongoing Vido Clinical Trials and Financial Outlook,5/10/2024 5:26:02 AM
IMUX,IMUX Stock Earnings: Immunic Misses EPS for Q1 2024,5/8/2024 2:54:08 PM
IMUX,Immunic Q1 2024 Earnings Preview,5/7/2024 6:13:32 PM
IMUX,Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Immunic (IMUX),4/16/2024 6:50:16 AM
IMUX,"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), DocGo (DCGO) and Alkermes (ALKS)",4/10/2024 11:20:24 AM
IMUX,"Brookline Capital starts Immunic at buy, cites MS drug candidate",4/5/2024 5:00:48 PM
IMUX,"Catalyst Watch: Walgreens earnings, UPS analyst day and Xiaomi's luxury EV debut",3/22/2024 7:00:00 PM
IMUX,Immunic And 2 Other Stocks Under $2 Insiders Are Buying,2/29/2024 4:40:10 PM
IMUX,Hold Rating on Immunic: Balancing Long-Term Potential Against Short-Term Uncertainties,2/26/2024 4:29:25 AM
IMUX,Buy Rating Affirmed for Immunic Amid Progress in IMU-838 Trials and Extended Financial Runway,2/22/2024 6:36:15 PM
IMUX,Notable earnings before Thursday's open,2/21/2024 2:42:51 PM
IMUX,Immunicto Privately Place Up To $240 Mln Of Shares; Stock Up In Pre-market ,1/5/2024 1:17:01 PM
IMUX,Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis,11/21/2023 12:30:00 PM
IMUX,Analysts Offer Insights on Healthcare Companies: Trevena (TRVN) and Immunic (IMUX),11/14/2023 7:40:08 PM
IMUX,Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts,11/2/2023 11:30:00 AM
IMUX,Immunic to Participate in Scientific and Industry Conferences in November,10/26/2023 12:30:00 PM
IMUX,Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023,10/16/2023 12:30:00 PM
IMUX,Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023,10/15/2023 12:30:00 PM
IMUX,Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting,10/11/2023 12:30:00 PM
IMUX,Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,10/10/2023 7:08:46 PM
IMUX,Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis,10/9/2023 10:01:00 PM
IMUX,"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Amgen (AMGN) and Neurocrine (NBIX)",10/6/2023 11:21:36 AM
IMUX,Immunic to Participate in Scientific Conferences in October,10/4/2023 12:30:00 PM
IMUX,Immunic to Participate in Industry and Investor Conferences in September,9/6/2023 12:30:00 PM
IMUX,Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis,8/17/2023 12:30:00 PM
IMUX,Wedbush Sticks to Its Buy Rating for Immunic (IMUX),8/4/2023 10:55:21 AM
IMUX,Immunic GAAP EPS of -$0.54 misses by $0.01,8/3/2023 10:42:30 AM
IMUX,Immunic to Participate in Investor and Scientific Conferences in August,8/1/2023 12:30:00 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update",7/27/2023 12:30:00 PM
IMUX,"Ensysce, Journey Medical top healthcare gainers; Protagonist, VBI Vaccines among losers",7/3/2023 2:30:53 PM
IMUX,"XPEV, ACHR and BTAI are among pre market gainers",6/30/2023 12:40:05 PM
IMUX,Immunic to Participate in Scientific and Investor Conferences in July,6/29/2023 12:30:00 PM
IMUX,"IONQ, LILM and IMUX among mid-day movers",6/28/2023 5:55:47 PM
IMUX,"These 2 ‘Strong Buy’ Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler",6/27/2023 1:56:03 PM
IMUX,Immunic to Participate in Scientific and Investor Conferences in June,5/30/2023 12:30:00 PM
IMUX,"Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis",5/17/2023 12:30:00 PM
IMUX,Wedbush Keeps Their Buy Rating on Immunic (IMUX),5/16/2023 10:45:09 AM
IMUX,Immunic (IMUX) Receives a Rating Update from a Top Analyst,5/15/2023 10:06:17 AM
IMUX,Immunic GAAP EPS of -$0.58 misses by $0.06,5/11/2023 10:59:40 AM
IMUX,"Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2023, and Provide Corporate Update",5/9/2023 12:30:00 PM
IMUX,Immunic gains after early-stage data for bowel disease candidate,5/8/2023 7:35:50 PM
IMUX,"Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action",5/6/2023 12:30:00 PM
IMUX,Immunic (IMUX) Receives a Rating Update from a Top Analyst,5/5/2023 3:16:25 PM
IMUX,"Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders",5/4/2023 12:30:00 PM
IMUX,"Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.",4/27/2023 12:30:00 PM
IMUX,Immunic to Participate in Investor and Scientific Conferences in May,4/26/2023 12:30:00 PM
IMUX,Piper Sandler Gives a Buy Rating to Immunic (IMUX),4/21/2023 12:06:08 PM
IMUX,SVB Securities Reaffirms Their Hold Rating on Immunic (IMUX),4/7/2023 6:45:30 AM
IMUX,"Analysts Are Bullish on Top Healthcare Stocks: Immunic (IMUX), Bioxcel Therapeutics (BTAI)",4/6/2023 11:00:20 AM
IMUX,Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,4/5/2023 7:33:38 PM
IMUX,Immunic to Participate in Investor and Scientific Conferences in March,3/2/2023 12:30:00 PM
IMUX,"Analysts Offer Insights on Healthcare Companies: CytomX Therapeutics (CTMX), Edgewise Therapeutics (EWTX) and Immunic (IMUX)",2/24/2023 7:00:41 PM
IMUX,Immunic GAAP EPS of -$3.78 misses by $0.88,2/23/2023 11:33:58 AM
IMUX,Immunic FY 2022 Earnings Preview,2/22/2023 6:05:46 PM
IMUX,"Catalyst watch: Spotlight on retail earnings, Lucid Group, Silvergate Capital and Radware",2/17/2023 8:00:02 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update",2/16/2023 12:30:00 PM
IMUX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Tenet Healthcare (THC), Replimune Group (REPL) and Immunic (IMUX)",2/13/2023 5:50:24 AM
IMUX,Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Envista Holdings (NVST),2/10/2023 12:20:29 PM
IMUX,Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need,2/9/2023 12:30:00 PM
IMUX,"Catalyst watch: Google talks AI, Nordstrom drama and Canada Goose event",2/3/2023 7:30:12 PM
IMUX,Immunic adds 14% as Wedbush initiates with bullish view on lead asset,1/31/2023 6:29:59 PM
IMUX,Immunic to Participate in Scientific and Investor Conferences in February,1/25/2023 12:30:00 PM
IMUX,Immunic (IMUX) Receives a Buy from Wedbush,11/21/2022 11:45:10 AM
IMUX,Immunic : Data Show Encouraging Signals For Vidofludimus Calcium For Delaying Disability Worsening ,11/17/2022 12:51:59 PM
IMUX,Immunic to Participate in Investor and Scientific Conferences in November and December,11/10/2022 12:30:00 PM
IMUX,Immunic (IMUX) Gets a Hold from SVB Securities,11/7/2022 3:26:42 AM
IMUX,Wedbush Remains a Buy on Immunic (IMUX),11/4/2022 3:55:28 PM
IMUX,Immunic GAAP EPS of -$0.69 misses by $0.03,11/3/2022 10:37:18 AM
IMUX,Immunic Q3 2022 Earnings Preview,11/2/2022 4:31:57 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update",10/27/2022 12:30:00 PM
IMUX,"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), SCYNEXIS (SCYX) and Karuna Therapeutics (KRTX)",10/26/2022 7:41:13 PM
IMUX,"WOLF,SLA and XERS are among pre market gainers",10/24/2022 12:15:55 PM
IMUX,Analyst Downgrades Immunic After Lack of Details Drive Uncertainty,10/21/2022 9:14:37 PM
IMUX,Immunic Reports Pre-Planned Phase 1b Interim Analysis of IMU-935 in Psoriasis Patients Confounded by High Placebo Rate,10/20/2022 10:01:00 PM
IMUX,"Ambrx, MorphoSys top healthcare gainers; NGM, Minerva lead losers' pack",10/17/2022 2:03:35 PM
IMUX,"Avenue, IMARA lead healthcare gainers; Galecto, Travere among losers",10/14/2022 2:00:10 PM
IMUX,Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket,10/13/2022 1:56:30 PM
IMUX,"Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session",10/12/2022 6:00:16 PM
IMUX,"IMUX, QNGY and HKD among mid-day movers",10/11/2022 4:43:43 PM
IMUX,Dow Rises 30 Points; Crude Oil Down 2%,10/10/2022 9:20:14 PM
IMUX,Immunic to Participate in Scientific and Industry Conferences in October,10/4/2022 12:30:00 PM
IMUX,SVB Securities Sticks to Its Buy Rating for Immunic (IMUX),9/23/2022 4:35:16 AM
IMUX,Wedbush Reaffirms Their Buy Rating on Immunic (IMUX),9/21/2022 10:35:12 AM
IMUX,"Immunic: Data Shows Favorable Pharmacokinetic Profile For IMU-856 In Single, 14-Day Multiple Dosing ",9/20/2022 12:45:53 PM
IMUX,"Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger",9/19/2022 9:03:31 PM
IMUX,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday,9/9/2022 11:35:14 AM
IMUX,"Immunic, Inc. to Participate in Investor Conferences in September",9/1/2022 12:30:00 PM
IMUX,Immunic To Announce Celiac Trial Data Next Month ,8/30/2022 9:37:16 AM
IMUX,"Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States for IMU-856, a Small Molecule Modulator Targeting Restoration of Intestinal Barrier Function and Regenera...",8/16/2022 12:30:00 PM
IMUX,Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday,8/5/2022 12:13:00 PM
IMUX,"Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session",8/4/2022 7:12:21 PM
IMUX,Notable earnings before Thursday's open,8/3/2022 2:45:21 PM
IMUX,"Immunic, Inc. to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference",8/2/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update",7/28/2022 12:30:00 PM
IMUX,"Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén",7/6/2022 12:30:00 PM
IMUX,Immunic to Participate in Industry and Scientific Conferences in July,6/28/2022 12:30:00 PM
IMUX,"Immunic Announces Publication of Data From Its Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in Peer Reviewed Journal, Annals of Clinical and Translation...",6/15/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June",6/8/2022 12:30:00 PM
IMUX,74 Biggest Movers From Yesterday,6/3/2022 11:50:47 AM
IMUX,Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide,6/2/2022 8:30:24 PM
IMUX,"The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves",5/10/2022 3:23:19 PM
IMUX,Notable earnings before Tuesday's open,5/9/2022 3:06:23 PM
IMUX,Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease,5/5/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update",5/3/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Participate in Upcoming Investor and Industry Conferences",4/25/2022 12:30:00 PM
IMUX,"The Daily Biotech Pulse:  Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study",3/16/2022 1:02:21 PM
IMUX,"Immunic, Inc. to Participate in Investor and Scientific Conferences in March",3/8/2022 12:30:00 PM
IMUX,Immunic GAAP EPS of -$3.93 misses by $0.04,2/24/2022 11:40:30 AM
IMUX,Immunic FY 2021 Earnings Preview,2/23/2022 4:06:20 PM
IMUX,"Immunic, Inc. to Present Preclinical Data for Vidofludimus Calcium at the 17th Congress of European Crohn's and Colitis Organization and Announces Blinded Baseline Characteristics of its Phase 2 C...",2/18/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update",2/17/2022 12:30:00 PM
IMUX,"Immunic, Inc. to Participate in Investor and Scientific Conferences in February",2/8/2022 12:30:00 PM
IMUX,"Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor",2/2/2022 10:01:00 PM
IMUX,34 Stocks Moving In Tuesday's Mid-Day Session,2/1/2022 7:46:32 PM
IMUX,60 Biggest Movers From Yesterday,1/11/2022 10:52:59 AM
IMUX,61 Biggest Movers From Yesterday,1/4/2022 11:06:34 AM
IMUX,35 Stocks Moving In Monday's Mid-Day Session,1/3/2022 6:06:06 PM
IMUX,Immunic's IMU-935 Demonstrates Favorable Safety Profile In Phase I Trial ,12/14/2021 1:39:34 PM
IMUX,"Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer",12/9/2021 10:01:00 PM
IMUX,"Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference",11/23/2021 12:30:00 PM
IMUX,"Immunic, Inc. Announces Enrollment of First Patient in its Phase 3 ENSURE Program of vidofludimus calcium (IMU-838) in Relapsing Multiple Sclerosis",11/18/2021 10:01:00 PM
IMUX,Immunic EPS beats by $0.02,11/4/2021 10:41:31 AM
IMUX,Notable earnings before Thursday's open,11/3/2021 3:55:55 PM
IMUX,"Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide Corporate Update",11/1/2021 11:30:00 AM
IMUX,"Immunic, Inc. Announces Completion of Enrollment of its Phase 2 CALDOSE-1 Trial of IMU-838 in Moderate-to-Severe Ulcerative Colitis",10/28/2021 12:30:00 PM
IMUX,"Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935",10/27/2021 12:30:00 PM
IMUX,"Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer",10/14/2021 12:30:00 PM
IMUX,"The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results",10/7/2021 2:23:53 PM
IMUX,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",10/6/2021 1:33:33 PM
IMUX,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",10/5/2021 2:01:45 PM
IMUX,"Immunic, Inc. Enrolls First Patient in Its Phase 2 CALLIPER Trial of IMU-838 in Progressive Multiple Sclerosis",9/30/2021 12:30:00 PM
IMUX,"Immunic, Inc. to Participate in Scientific and Investor Conferences in October",9/28/2021 12:30:00 PM
IMUX,"Immunic, German University Sign License Deal To Treat Viral Infections; Terms Not Disclosed ",9/22/2021 12:58:41 PM
IMUX,"Immunic, Inc. to Participate in Investor and Scientific Conferences in September",9/8/2021 12:30:00 PM
IMUX,10 Biggest Price Target Changes For Tuesday,9/7/2021 2:33:21 PM
IMUX,84 Biggest Movers From Friday,8/9/2021 11:20:59 AM
IMUX,"The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO",8/6/2021 1:42:39 PM
IMUX,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",8/5/2021 2:07:56 PM
IMUX,"Immunic, Inc. to Participate in Investor Conferences in August",8/3/2021 12:30:00 PM
IMUX,"The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study",7/16/2021 1:37:29 PM
IMUX,32 Stocks Moving In Thursday's Mid-Day Session,7/15/2021 6:00:10 PM
IMUX,Immunic announces common stock public offering,7/14/2021 8:17:14 PM
IMUX,"Immunic, Inc. to Host Virtual R&D Day Today to Provide an Update on the Preclinical and Clinical Development of IMU-935, a Potentially Best-in-Class RORγt Inverse Agonist",7/12/2021 12:30:00 PM
IMUX,"The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts",7/1/2021 2:06:57 PM
IMUX,"Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in July",6/28/2021 12:30:00 PM
IMUX,"Immunic, Inc. to Participate in Industry and Investor Conferences in June",6/10/2021 12:30:00 PM
IMUX,72 Biggest Movers From Yesterday,5/7/2021 11:10:34 AM
IMUX,"Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today",4/15/2021 6:51:27 PM
IMUX,Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect,3/24/2021 5:26:39 PM
IMUX,Immunic EPS beats by $0.05,2/26/2021 11:46:30 AM
IMUX,"PETS, IMUX, EVGN and OTIC among after-hours movers",2/19/2021 10:46:06 PM
IMUX,Immunic's IMU-838 Shows Promising Clinical Effect In Mid-Stage Liver Disease Study,2/18/2021 2:26:03 PM
IMUX,70 Stocks Moving In Wednesday's Mid-Day Session,2/17/2021 6:19:39 PM
IMUX,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",12/26/2020 3:15:52 PM
IMUX,"IDEAYA Biosciences, I-Mab & Immunic will be added to NASDAQ Biotechnology Index",12/14/2020 8:50:34 PM
IMUX,"Sundial Growers, DiaMedica Therapeutics leads healthcare gainers; Medigus, Graybug Vision among major losers",11/24/2020 4:05:32 PM
IMUX,Immunic Enrolls 200 Patients In Phase 2 CALVID-1 Trial Of IMU-838 - Quick Facts ,11/2/2020 1:09:22 PM
IMUX,Immunic secures €24.5M in loan financing,10/20/2020 3:35:13 PM
IMUX,Immunic: Data Monitoring Committee Recommends To Continue CALVID-1 Trial Without Changes ,9/28/2020 1:38:24 PM
IMUX,"Pre-market Movers In Healthcare Sector: FLDM, IMUX, LPCN, SRNE, ZSAN… ",8/26/2020 12:25:54 PM
IMUX,"ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. ",8/4/2020 9:31:42 AM
IMUX,Stock Alert: Immunic Up 20% On Positive Mid-Stage Trial Results Of Multiple Sclerosis Treatment ,8/3/2020 5:04:27 PM
IMUX,Dosing underway in mid-stage study of Immunic's IMU-838 in COVID-19,6/15/2020 2:07:40 PM
IMUX,Immunic prices equity offering at $11.40,6/10/2020 1:56:48 PM
IMUX,Immunic Receives FDA Authorization To Initiate Phase 2 CALVID-1 Trial On COVID-19 ,6/9/2020 1:54:04 PM
IMUX,Healthcare - Top 5 Gainers / Losers,6/5/2020 3:01:38 PM
IMUX,Stock Alert: Immunic Shares Jump 35% In Late Trade ,5/14/2020 7:32:54 AM
IMUX,Immunic on go to launch study of IMU-838 in COVID-19,5/13/2020 8:11:00 PM
IMUX,"CAH, BLUE among premarket gainers",5/11/2020 1:26:02 PM
IMUX,Neptune Wellness leads healthcare gainers; Immunic and ReWalk Robotics among losers,4/23/2020 3:02:52 PM
IMUX,"LB, WATT, SNAP and DKL among midday movers",4/22/2020 4:43:46 PM
IMUX,Immunic up 16% after hours on potential COVID-19 drug,4/21/2020 8:08:21 PM
IMUX,"TWO, ARI, GOGO and TTOO among midday movers",3/25/2020 4:42:23 PM
IMUX,BioNTech and Vaxart among healthcare gainers; DBV Technologies leads the losers,3/17/2020 2:59:53 PM
IMUX,Immunic reports FY results,3/16/2020 9:28:44 PM
IMUX,Catalysts Ahead: Will These 4 Pharma Stocks Hit Or Miss The Mark? ,8/2/2019 1:04:50 PM
IMUX,"6 Top Gainers In Healthcare Sector (AMRN, DOVA, IMUX...) ",7/3/2019 4:12:18 AM
IMUX,"5 Top Gainers In Healthcare Sector (IMUX, KRYS, NERV...) ",6/25/2019 3:47:43 AM
IMUX,"6 Top Gainers In Healthcare Sector (ATOS, AKTX, ATHX...) ",4/24/2019 4:21:49 AM
